Medica S.p.A. Stock

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana 11:44:59 2024-05-09 am EDT 5-day change 1st Jan Change
26.8 EUR +0.75% Intraday chart for Medica S.p.A. +1.52% +72.90%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2023 79.98M 86.25M Sales 2024 * 93.11M 100M Capitalization 113M 122M
Net income 2023 2M 2.16M Net income 2024 * 6M 6.47M EV / Sales 2023 0.82 x
Net Debt 2023 * 10.35M 11.16M Net Debt 2024 * 5.92M 6.38M EV / Sales 2024 * 1.28 x
P/E ratio 2023 *
56.4 x
P/E ratio 2024 *
16.6 x
Employees 676
Yield 2023 *
-
Yield 2024 *
-
Free-Float 20.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.75%
1 week+1.52%
Current month+1.52%
1 month+39.58%
3 months+64.42%
6 months+54.91%
Current year+72.90%
More quotes
1 week
26.40
Extreme 26.4
26.80
1 month
18.60
Extreme 18.6
26.80
Current year
14.50
Extreme 14.5
26.80
1 year
14.40
Extreme 14.4
26.80
3 years
14.40
Extreme 14.4
45.80
5 years
14.40
Extreme 14.4
45.80
10 years
14.40
Extreme 14.4
45.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 10-12-31
Chairman 75 89-12-31
Chief Administrative Officer 58 94-12-31
Members of the board TitleAgeSince
Director/Board Member 54 21-10-13
Chairman 75 89-12-31
Chief Executive Officer 41 10-12-31
More insiders
Date Price Change Volume
24-05-09 26.8 +0.75% 14,050
24-05-08 26.6 +0.76% 15,050
24-05-07 26.4 -0.75% 2,500
24-05-06 26.6 +0.76% 1,350
24-05-03 26.4 -0.75% 12,150

Real-time Borsa Italiana, May 09, 2024 at 11:44 am EDT

More quotes
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.8 EUR
Average target price
31.4 EUR
Spread / Average Target
+17.16%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW